Corzo Santamaría, Teresa; Portela, José; Schwartz, … - National Bureau of Economic Research - 2026
Geopolitical tensions, supply-chain concerns and policy risk have moved to the forefront of the pharmaceutical industry. This paper develops a real options valuation model of drug R&D that captures sequential clinical investment with technical failure, stochastic costs, uncertain cash flows, and...